0
0.0
Apr 30, 2024
04/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
matteson: -- madison: eli lilly is looking at zepbound and sleep apnea. that could widen medicare to expand it to even more patients. if they are seeing a significant improvement in supply, at least that is what they are saying, in the second half of the year into early 2025 with more and more plants coming online that will start producing the drugs. part of this is widening access. more insurers covering the drugs, hopefully, and also more supply coming online. sonali: what are the risks at this point? is it a competitive risk or is it a pain for the service risk here? when you think about insurance, where are the biggest concerns among investors? madison: the biggest concern among investors was the supply challenge, being able to meet the seemingly endless demand for the drugs. eli lilly said they don't actually have manufacturing or supply issues. the problem is, there is just a finite amount of manufacturing capacity for these injectable medicines. so, they are having to build new capacity into the system and if that takes a little time to come on min
matteson: -- madison: eli lilly is looking at zepbound and sleep apnea. that could widen medicare to expand it to even more patients. if they are seeing a significant improvement in supply, at least that is what they are saying, in the second half of the year into early 2025 with more and more plants coming online that will start producing the drugs. part of this is widening access. more insurers covering the drugs, hopefully, and also more supply coming online. sonali: what are the risks at...
0
0.0
Apr 30, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >>> eli lilly set to report. ceo david ricks will join us in the first on cnbc interview in the 7:00 hour. >> it's aabrupt. >> you get a rental. at corient, wealth management begins and ends with you. we believe the more personal the solution, the more powerful the result. we treat your goals as our own. we never lose focus on the life you want to build. and our experienced advisors design custom built strategies to help you get there. it's time for a wealth management experience as sophisticated as you are. it's time for corient. >>> the national highway traffic safety administration finalized a new rule to require all new passenger vehicles to include automatic emergency braking. the government says it will save lives and prevent thousands of injuries each year. it will require vehicles to apply the brakes automatically to avoid collisions and stop for pedestrians during the day and night. >> it is already in a lot of cars now. it will be required in every car. >> yup. >> it's a good thing. >> jarring. >> it he
. >>> eli lilly set to report. ceo david ricks will join us in the first on cnbc interview in the 7:00 hour. >> it's aabrupt. >> you get a rental. at corient, wealth management begins and ends with you. we believe the more personal the solution, the more powerful the result. we treat your goals as our own. we never lose focus on the life you want to build. and our experienced advisors design custom built strategies to help you get there. it's time for a wealth management...
0
0.0
Apr 17, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
eli lilly. as a whole, you're going to need a bunch of different solutions to solve the same issue. >> the episodes of breathing problems while you're sleeping is reduced by 60%. you still have problematic episodes of hypoxia and apnea while you're sleeping. it's a step in the right direction. it's a reduction and not an entire cure, drugs will still have to be used, breathing devices still have to be used. there still might be surgical interventions to cure sleep apnea. it's not like this drug can address it and all these other things go away, which had been the binary thinking initially when we heard about the study. >> we were wondering why is inspire not down okay, the trial sounds good, but it wasn't good enough for you to not need anything else the whole thing is so amazing, the number of different applications of these drugs, it's extraordinary >> yeah. so does it merit this valuation? >> does it merit getting insurance coverage >> some are saying, yes, it will open it up to medicare cove
eli lilly. as a whole, you're going to need a bunch of different solutions to solve the same issue. >> the episodes of breathing problems while you're sleeping is reduced by 60%. you still have problematic episodes of hypoxia and apnea while you're sleeping. it's a step in the right direction. it's a reduction and not an entire cure, drugs will still have to be used, breathing devices still have to be used. there still might be surgical interventions to cure sleep apnea. it's not like...
0
0.0
Apr 30, 2024
04/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
eli lilly knocking it out of the park. really fun to watch earnings later this week. but let's go from weight loss drugs to fast food because young china not having a great day. emily: not as good. this is the operator of chain restaurants including pizza hut, kfc, taco bell in china. that stock is down 6%. it was a first quarter revenue missed at $296 billion is estimates of $300 billion. when you look at the comps for kfc, those were misses. mike keep suffering -- might macro story we can learn about consumers in china may be pulling back -- maybe pulling back on ordering fast food even though it is cheaper than other food alternatives. katie: even still, you look at the shares down 8% on the day. let's bring it home with paypal because we are really in the thick of earnings season right now. emily: there are so many reports each day. this one was a pretty solid beat for the payment company. total payment volume beat at $4.03 billion, up year-over-year, beating estimates, net revenue also beat. interesting story out of paypal as they are looking to right size the bu
eli lilly knocking it out of the park. really fun to watch earnings later this week. but let's go from weight loss drugs to fast food because young china not having a great day. emily: not as good. this is the operator of chain restaurants including pizza hut, kfc, taco bell in china. that stock is down 6%. it was a first quarter revenue missed at $296 billion is estimates of $300 billion. when you look at the comps for kfc, those were misses. mike keep suffering -- might macro story we can...
0
0.0
Apr 29, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
's and mounjaro and mcdonald's and eli lilly, that's in "earnings exchange" next to start a business, you need an idea. it's a pillow with a speaker in it! that's right craig. a team that's highly competent. i'm just here for the internets. at&t it's super-fast. reliable. you locked us out?! arrggghh! ahhhh! solution-oriented. [jenna screams] and most importantly... is the internet out? don't worry, we have at&t internet back-up. the next level network. i sold a pillow! you're probably not easily persuaded to switch mobile providers for your business. but what if we told you it's possible that comcast business mobile can save you up to 75% a year on your wireless bill versus the big three carriers? you can get two unlimited lines for just $30 each a month. all on the most reliable 5g mobile network—nationwide. wireless that works for you. for a limited time, ask how to save up to $830 off an eligible 5g phone when you switch to comcast business mobile. don't wait! call, click or visit an xfinity store today. >>> welcome back took "the exchange." we're looking at the help of consume
's and mounjaro and mcdonald's and eli lilly, that's in "earnings exchange" next to start a business, you need an idea. it's a pillow with a speaker in it! that's right craig. a team that's highly competent. i'm just here for the internets. at&t it's super-fast. reliable. you locked us out?! arrggghh! ahhhh! solution-oriented. [jenna screams] and most importantly... is the internet out? don't worry, we have at&t internet back-up. the next level network. i sold a pillow! you're...
0
0.0
Apr 11, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
home of eli lilly. >> i like eli lilly. i'm looking at eli lilly to be the next trillion-dollar stock. what's happening? >> caller: i wanted to let you know that i just joined your investing club two weeks ago. >> oh, fantastic. >> caller: and you know, for what you're offering for less than a dollar a day it's a steal. >> oh, thank you. thank you. that's terrific. thank you, michael. what'sgoing on? >> caller: hey, i wanted to talk to you about this well-known stock that was just recently around 195 but it's recently taken a beating. it's p/e, dividend yield and net margin are allvastly superior to one of your favorites, chipotle. what are your thoughts on mcdonald's? >> okay, mcdonald's raised their price too much. that's one of the things i saw in the cpi number yesterday i didn't like. i think mcdonald's has contributed to that. they have to pull back prices. nobody in this business ever wants to lower prices. this is time for what we call a philip morris moment for mcdonald's. they have to do something they did in the
home of eli lilly. >> i like eli lilly. i'm looking at eli lilly to be the next trillion-dollar stock. what's happening? >> caller: i wanted to let you know that i just joined your investing club two weeks ago. >> oh, fantastic. >> caller: and you know, for what you're offering for less than a dollar a day it's a steal. >> oh, thank you. thank you. that's terrific. thank you, michael. what'sgoing on? >> caller: hey, i wanted to talk to you about this...
0
0.0
Apr 30, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
lilly and mcdonald's reporting mixed results this morning, eli lilly stock is on fires this morning, the take a look at that stock which is showing a gain of 7%, almost 7%, 3m is up almost 8% this morning. mcdonald's down 2%. coca-cola reported a double beat on earnings and revenue but the stock is down a fraction. boycotts in the middle east weighing on mcdonald's and coca-cola's international sales. we'll get amazon after the bell tonight. that will likely be a market mover because it gives us a window into the consumer. followed by cvs health and then tomorrow cvs health and a apple is out on thursday, mark. what is your reaction to the earnings you've seen so far? are there trends that you can take away and what are you expecting from the big one, which is apple on thursday. >> let's start with this morning. i think it's pretty interesting that you have eli lilly, mcdonald's and coca-cola all reporting this morning because as cheryl and i were talking about, this is a trend that's going to be a strong trend, strong theme over the course of the next five to 10 years which is the g
lilly and mcdonald's reporting mixed results this morning, eli lilly stock is on fires this morning, the take a look at that stock which is showing a gain of 7%, almost 7%, 3m is up almost 8% this morning. mcdonald's down 2%. coca-cola reported a double beat on earnings and revenue but the stock is down a fraction. boycotts in the middle east weighing on mcdonald's and coca-cola's international sales. we'll get amazon after the bell tonight. that will likely be a market mover because it gives...
0
0.0
Apr 30, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
eli lilly had a great day on a terrific quarter related to the salesof the weight loss and diabetes drugs. 3m gave you of upside surprised even as it came with a dividend cut. the bond market crushed the stock market yet again. i want to step back for a moment and tell you how i see this meltdown. first, it's the end of the month and money managers like to sell stocks en masse at the end of the month that's been bad. we might be waiting through a technical brush we don't even know about. second, with consumer confidence for april falling to the lowest level since july of 22 in two that's more likely going to produce a softer set of retail numbers something that we very much ant to see. consumers get negative for a bunch of reasons. it could be the protest that dominate deadlines could be the presidential election or because people are suddenly worried about keeping their jobs and that is something that may weigh on fridays payroll number if it is weak again. third, today's week chicago pmi number could be assigned the u.s. economy juggernaut may have run out of steam or is not operating a
eli lilly had a great day on a terrific quarter related to the salesof the weight loss and diabetes drugs. 3m gave you of upside surprised even as it came with a dividend cut. the bond market crushed the stock market yet again. i want to step back for a moment and tell you how i see this meltdown. first, it's the end of the month and money managers like to sell stocks en masse at the end of the month that's been bad. we might be waiting through a technical brush we don't even know about....
0
0.0
Apr 18, 2024
04/24
by
KGO
tv
eye 0
favorite 0
quote 0
. >> drug maker eli lilly says it's found a new use for its popular weight loss drug. zep bound research say it can also treat sleep apnea on top of obesity. >> what we saw in patients was up to a two thirds reduction in the severity of their sleep apnea. >> the study looked at people with moderate to severe sleep apnea, both with and without cpap therapy. and not only did the drug lower apnea events by up to 63. their data shows it also reduced body weight by up to 20, and apnea event is when someone stops breathing or doesn't breathe enough while sleeping. in many patients, it went from about 45 events an hour to just 15. >> we believe that this medicine removes fat around the airway, which reduces sort of the cause of sleep apnea, which is that the excess tissue that causes the airways to collapse the once a week injectable treatment isn't new. >> under the name manjaro, it's approved to treat type two diabetes under the name zep bound. it treats weight loss. >> the generic name is called tirzepatide, and then we commonly use these brand names, which confuses people
. >> drug maker eli lilly says it's found a new use for its popular weight loss drug. zep bound research say it can also treat sleep apnea on top of obesity. >> what we saw in patients was up to a two thirds reduction in the severity of their sleep apnea. >> the study looked at people with moderate to severe sleep apnea, both with and without cpap therapy. and not only did the drug lower apnea events by up to 63. their data shows it also reduced body weight by up to 20, and...
0
0.0
Apr 30, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
they want eli lilly. they're not staying thick and thin from mcdon't's. >> maybe eli lilly is another reason why people aren't eating as many burgers. i don't know. was it a year ago where so many companies that relied on people's appetites, had a significant impact on the eating ability of the american consumer. the glp-1 numbers only continue to go up, up, up, up, and by the way, the number of different mam different maladies that can be treated. >> they say sales are actually up because people are discovering they have this from the glp-1 when they go with the doctors. it's part of obesity. their sales have gone up. i asked james quincey this morning, is it possible, coca-cola, the numbers have gone up because you can drink as much as you can't and not gain weight. >> it's different from when we saw that spoon in so many of those stocks? >> he said what it really is they like diet coke and coke zero, those numbers are up big. >> as it pro live rates through the population -- >> it's liquor that has bee
they want eli lilly. they're not staying thick and thin from mcdon't's. >> maybe eli lilly is another reason why people aren't eating as many burgers. i don't know. was it a year ago where so many companies that relied on people's appetites, had a significant impact on the eating ability of the american consumer. the glp-1 numbers only continue to go up, up, up, up, and by the way, the number of different mam different maladies that can be treated. >> they say sales are actually up...
0
0.0
Apr 17, 2024
04/24
by
KTVU
tv
eye 0
favorite 0
quote 0
. >> what drugmaker eli lilly says about new research of z-band and how it could help ople with china into indonesia. apple ceo tim cook met with indonesia's president this morning in jakarta, discussing the investment possibilities. apple is seeking to diversify its supply chain away from china. the move is also part of an effort by indonesia to bring in more manufacturing. >> i think the investment ability in indonesia is endless. i think that there's a lot of great places to invest and we're investing. we believe in the country. >> thank you. >> cook's visit came after apple announced its fourth app developer academy in indonesia, on the island of bali. apple launched the program to train app developers in indonesia back in 2018. a new study found a popular weight loss drug may do more than just help people shed unwanted pounds. drugmaker eli lilly says its obesity drug zeppelin may help people with obstructive sleep apnea, a disorder that causes people to briefly stop breathing while they sleep. the study showed people had fewer breathing issues while using zeppelin compared to th
. >> what drugmaker eli lilly says about new research of z-band and how it could help ople with china into indonesia. apple ceo tim cook met with indonesia's president this morning in jakarta, discussing the investment possibilities. apple is seeking to diversify its supply chain away from china. the move is also part of an effort by indonesia to bring in more manufacturing. >> i think the investment ability in indonesia is endless. i think that there's a lot of great places to...
0
0.0
Apr 18, 2024
04/24
by
KGO
tv
eye 0
favorite 0
quote 0
. >> drug maker eli lilly says it's found a new use for its popular weight loss drug. zep bound research say it can also treat sleep apnea on top of obesity. >> what we saw in patients was up to a new use for its popular weight loss drug. zep bound research say it can also treat sleep apnea on top of obesity. >> what we saw in patients was up to a t injectable treatment isn't new. >> under the name manjaro, it's approved to treat type two diabetes under the name zep bound. it treats weight loss. >> the generic name is called tirzepatide, and then we commonly use these brand names, which confuses people. >> doctor raj dasgupta is excited about having another weapon for sleep apnea, but he thinks it's only one piece of the puzzle. >> is this going to be the magic bullet? is this going to be the drug? and now you don't need to get evaluated. you don't need cpap, you don't need to do other things. i don't think we're at that stage yet. >> well, this may be a turning point for sleep apnea patients, he says. we still need to learn more about the long tum effects. >> when we
. >> drug maker eli lilly says it's found a new use for its popular weight loss drug. zep bound research say it can also treat sleep apnea on top of obesity. >> what we saw in patients was up to a new use for its popular weight loss drug. zep bound research say it can also treat sleep apnea on top of obesity. >> what we saw in patients was up to a t injectable treatment isn't new. >> under the name manjaro, it's approved to treat type two diabetes under the name zep...
0
0.0
Apr 30, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
it was up 8% or 9%, a huge success for eli lilly. late this afternoon, amazon releases its latest quarterly results, what you've got to be interested in is there outlook for the future and their cloud business. looking forward to that report, stock is up $0.20, $181 a share. coming up on 10:51 eastern time and that means he will appear magically on the side of your screen, that right there is brian kilmeade. thanks for joining us, straight to this anti-israel protesters at columbia. they occupied this building, what do you think they should do? brian: how much longer can they hold out, they cut electricity right away, stop the water, number 2, you've got to tell the nypd be prepared to move in. you can't smash windows, take over building, holdback janitors against their will until they forced their way out and that your answer to at 2:00 pm deadline to pick up your tents and go home and clear the square? at some point faculty has to step up. here's the leverage. 23 congressional democrats told the administration get your act together
it was up 8% or 9%, a huge success for eli lilly. late this afternoon, amazon releases its latest quarterly results, what you've got to be interested in is there outlook for the future and their cloud business. looking forward to that report, stock is up $0.20, $181 a share. coming up on 10:51 eastern time and that means he will appear magically on the side of your screen, that right there is brian kilmeade. thanks for joining us, straight to this anti-israel protesters at columbia. they...
0
0.0
Apr 30, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
we hear from eli lilly and coca-cola and 3m in the next h hour. it is tuesday, april 30th. may is tomorrow. "squawk box" begins right now. >>> good morning. welcome to "squawk box" here on cnbc. we are live from the nasdaq market site in times square. i'm becky quick along with joe kernen and andrew ross sorkin. here we go. check out the u.s. equities. the markets closed higher yesterday. this morning, futures are down. dow futures off 20 points. nasdaq indicated down by 30. you have the s&p futures off close to 10. the treasury yields we have been watching continue to be in the same range. ten-year yield at 4.63. two-year yield at 4.98. >>> joe mentioned the breaking news at columbia university. protesters stormed the building which was coming hours after the leaders suspended students who refused to leave the
we hear from eli lilly and coca-cola and 3m in the next h hour. it is tuesday, april 30th. may is tomorrow. "squawk box" begins right now. >>> good morning. welcome to "squawk box" here on cnbc. we are live from the nasdaq market site in times square. i'm becky quick along with joe kernen and andrew ross sorkin. here we go. check out the u.s. equities. the markets closed higher yesterday. this morning, futures are down. dow futures off 20 points. nasdaq indicated...
0
0.0
Apr 30, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
no weight gain for patients on eli lilly's weight loss drug, big gains for the stock, up 5.3%, demand or for the drug led the farm a giant to raise its annual sales forecast by $2 billion and expect significant production, increases in the second half of the year, also related diabetes drug, demand for both% eli lilly's market soaring above $700 billion, greater than tesla and walmart. shares of ge healthcare looks likely down 13% sitting at the bottom of the nasdaq 100. they recently spun off from ge reported lower-than-expected financials for the first quarter at a drop and a drop in revenue. it did however affirm its full-year outlook expecting its growth trajectory to be weighted towards the back half of the year and warner bros. discovery calling for a foul by investors, the stock is sinking 9% on news it could lose broadcast rights for the national basketball association. comcast's nbc universal is jumping in offering to pay an average of $2.5 billion a year to broadcast basketball games with tnt network paying $1.2 billion in its current deal. w bd was unable to reach a new pac
no weight gain for patients on eli lilly's weight loss drug, big gains for the stock, up 5.3%, demand or for the drug led the farm a giant to raise its annual sales forecast by $2 billion and expect significant production, increases in the second half of the year, also related diabetes drug, demand for both% eli lilly's market soaring above $700 billion, greater than tesla and walmart. shares of ge healthcare looks likely down 13% sitting at the bottom of the nasdaq 100. they recently spun off...
0
0.0
tv
eye 0
favorite 0
quote 0
individual stocks we've got with news on, eli lilly, for example, it plans to spend big on an obesity drug plant. they're a going to make it. how much are they spending on it, and where are they going to build it? lauren: it's not the u.s., it's germany. and the amount is $2.5 billion. that plant opens in three years' time, in 2027, and it would produce mounjaro as well as the pens used to add a more the weight loss shot. why germany? because it's close to equipment manufacture if manufacturers that eli lilly already uses, and europe i don't want to say untapped, but the market for the weight loss drugs in europe is not as big as it is here. one reason is european unions has, ultimately, a a ban on insurance companies covering the weight loss market. stuart: oh, or ye with. hawaii. [laughter] lauren: pfizer is hobby being -- hour bying to change that. stuart: well, if the insurance companies are prepared to the pay for made -- or made to pay for it, the con suggests will go up. let's have a look at truth social. it's down again, 1%. $36 a share. lauren: wasn't that the price that it p
individual stocks we've got with news on, eli lilly, for example, it plans to spend big on an obesity drug plant. they're a going to make it. how much are they spending on it, and where are they going to build it? lauren: it's not the u.s., it's germany. and the amount is $2.5 billion. that plant opens in three years' time, in 2027, and it would produce mounjaro as well as the pens used to add a more the weight loss shot. why germany? because it's close to equipment manufacture if manufacturers...
0
0.0
Apr 30, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
eli lilly is back trading near all-time highs after posting a first quarter earnings beat and raising full-year guidance thanks in part to "greater visibility into its production and expansion of several drugs." here's what the ceo told "squawkbox" about that rollout this morning. >> our top priority is making more product, and we're doing everything we can do to that, recognizing that making medicine, and this is one of the most technically complicated medicines we have ever made. it's a protein therapeutic in an enclosed system that has to be sterile, and then injection device. so we're ramping that aggressively. but it's capital intensive, technically complex and highly regulated. >> today's move pushing the stock back into positive territory for april, putting it on pace for a four-month win streak, now up 35% since the start of the year. and that's saying something since it's a $739 billion market cap. not based in california or washington state but based in indiana. >>> coming up, amd versus super micro, awhich would you rather edition of earnings exchange is next. kraft heinz m
eli lilly is back trading near all-time highs after posting a first quarter earnings beat and raising full-year guidance thanks in part to "greater visibility into its production and expansion of several drugs." here's what the ceo told "squawkbox" about that rollout this morning. >> our top priority is making more product, and we're doing everything we can do to that, recognizing that making medicine, and this is one of the most technically complicated medicines we...
0
0.0
Apr 18, 2024
04/24
by
KNTV
tv
eye 0
favorite 0
quote 0
. >> i know you folks with executives of eli lilly. what are they saying about how they're trying to meet demand? >> they took me through a facility, a factory they're building in north carolina specifically to churn out mounjaro and zepbound, and they're working around the clock to try to beef up capacity. this is what they said about demand and how hard it is to keep up the supply. >> when do you think zepbound will be in better supply? >> yeah, for the near term we are going to be in this limited availability, which may cause delays across some of the doses for both mounjaro and zepbound just for the near term, we are expected limited availability. >> can't really give us a forecast for when things will be fully available for everybody. remember, every day new people are turning on to these drugs, especially since we're finding new advantages to some of them. sleep apnea is one thing. they're going to send it to the medical journals to publish those results. >> to the point of limited availability, if someone has been using these dr
. >> i know you folks with executives of eli lilly. what are they saying about how they're trying to meet demand? >> they took me through a facility, a factory they're building in north carolina specifically to churn out mounjaro and zepbound, and they're working around the clock to try to beef up capacity. this is what they said about demand and how hard it is to keep up the supply. >> when do you think zepbound will be in better supply? >> yeah, for the near term we...
0
0.0
Apr 30, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
in particular, eli lilly. that stock straight up today, 4% higher. lauren, i guess that's the weight loss drugs doing well. lauren: mounjaro, beat and raise kind of quarter thanks to skyrocketing demand for those weight loss and diabetes drugs. stock's up 4.5%. eli lilly's ceo says demand will outpace supply this year despite if making more, becoming their top careerty. can't do it. that's how big demand is. their market cap topping $7 billion. stuart: coca-cola, did they report this morning? lauren: yeah. and consumers are splurging on soda and juice when they go to restaurants, not at at a grocery store. stock's relatively flat, down a quarter, but they raised their prices 13% on average -- stuart: whoa. lauren: some pricing power. stuart: mcdonald's, were they out today before the bell? lauren: yeah. the stock down almost 4%. i guess when with it comes to fast food if chains, americans aren't splurging. they're becoming picky about their spending. in the u.s., same-store sales increased 355%, but -- 3.5%, but a year ago a, it was 212.5%. they're t
in particular, eli lilly. that stock straight up today, 4% higher. lauren, i guess that's the weight loss drugs doing well. lauren: mounjaro, beat and raise kind of quarter thanks to skyrocketing demand for those weight loss and diabetes drugs. stock's up 4.5%. eli lilly's ceo says demand will outpace supply this year despite if making more, becoming their top careerty. can't do it. that's how big demand is. their market cap topping $7 billion. stuart: coca-cola, did they report this morning?...
0
0.0
Apr 17, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
stuart: eli lilly, their weight loss drug, is it showing promise for sleep apnea treatment? lauren: this is huge. it would be the first pharmaceutical treatment for sleep apnea which 40 million americans suffer from. eli lilly released the result of two hate stage trials -- late stage trials in cults with sleep apnea, and the drugs reduced the we havety -- severity by 63%. companies like resmed that make sleep apnea machines, they're all down because this news from sepp bound is so good. stuart: how about travelers? insurance people, or obviously. they dropped 7. %. what's the problem? some. lauren: revenue from all three of their units came in below with estimates. catastrophe losses are widening. you had wind storms, you had hailstorms where i live with the hail, basically every other house on my block got a new roof because of the hailstorms. stuart: really? lauren: uh-huh. we tried to get our gutters fixed through insurance, and they said no. but our neighbors got a roof. >> did enough i damage? lauren: yes. >> that's the first requirement. [laughter] lauren: even when i
stuart: eli lilly, their weight loss drug, is it showing promise for sleep apnea treatment? lauren: this is huge. it would be the first pharmaceutical treatment for sleep apnea which 40 million americans suffer from. eli lilly released the result of two hate stage trials -- late stage trials in cults with sleep apnea, and the drugs reduced the we havety -- severity by 63%. companies like resmed that make sleep apnea machines, they're all down because this news from sepp bound is so good....
0
0.0
Apr 4, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
can we extrapolate the results to the glp-1 drugs that are marketed today by novo and eli lilly? >> yeah, i think it's an important kind of precedent that we need to watch, because we're seeing it's not just in parkinson's, but a lot of the other diseases that you and i and the team have spoken about, cardio metabolic diseases in general. so, i think this opens the door for thinking about linkages. and here's why. i think this is a disconnect. we know there's a relationship between people who are diagnosed with diabetes and the propencive to demonstrate parkinson's or parkinson's-like symptoms. so, we know there's some biologic relationship between that kind of insulin metabolic access, and that's why glp-1s can be very important. so, while this did not make the cut for being kind of competitive on the weight loss and diabetes race with glp-1s. that kind of mechanism of function in parkinson's and this early promising data, remember, it's not reversing parkinson's, but slowing down the symptoms for 12 months, that can be incredibly valuable to quality of life. and i think this ha
can we extrapolate the results to the glp-1 drugs that are marketed today by novo and eli lilly? >> yeah, i think it's an important kind of precedent that we need to watch, because we're seeing it's not just in parkinson's, but a lot of the other diseases that you and i and the team have spoken about, cardio metabolic diseases in general. so, i think this opens the door for thinking about linkages. and here's why. i think this is a disconnect. we know there's a relationship between people...
0
0.0
Apr 25, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
>> it was close and you guys almost convinced me to go with eli lilly because we have a hot dog eating guy and jillian and then i am sitting next to a guy who uses the drug to lose weight so i am like should i go with them but i am going with delta because i feel this is the first summer we are post covid where people have disposable income and they want to travel and they want to travel in style but on time and i am in atlanta and i used delta a lot and they are always on time and they have the vip service and all of those great things and i think people will say with my disposable income i want the best airline possibilities and delta is one of them and i'm going with delta. >> all right. we will take a quick break and all of the pics and we have more stock drafts coming up and gym kramers t cckowonhelo n and we will hear from him next and final thoughts from him as well and all 20 pics are in and we will size those up after this. i'm just here for the internets. at&t it's super-fast. reliable. you locked us out?! arrggghh! ahhhh! solution-oriented. [jenna screams] and most important
>> it was close and you guys almost convinced me to go with eli lilly because we have a hot dog eating guy and jillian and then i am sitting next to a guy who uses the drug to lose weight so i am like should i go with them but i am going with delta because i feel this is the first summer we are post covid where people have disposable income and they want to travel and they want to travel in style but on time and i am in atlanta and i used delta a lot and they are always on time and they...
0
0.0
Apr 10, 2024
04/24
by
KTVU
tv
eye 0
favorite 0
quote 0
drugmaker eli lilly announced 10,000,000 liter vials, ten milliliter vials of two types of insulin would be temporarily out of stock in some parts of the country through the beginning of april. many diabetics are finding that the insulin that is available is either not what they were prescribed, or it's not covered by their insurance. >> insulin is insulin, but you have to have the right name brand in order to get it covered , and insurance isn't going to do it if they don't have it, they will have high blood sugar levels, leading to several complications. >> especially it will start affecting their kidneys, their eyes, and other organs. >> eli lilly has promised to ship out the insulin as soon as it is manufactured, but has not given an exact date. >> the cdc says the financial cost of a mammogram is not the only barrier. keeping women from getting the potentially life saving procedure. a new study reveals only about 65% of women ages 50 to 74, with three or more health related social needs are up to date with their mammogram screenings. the cdc also says health related social needs inc
drugmaker eli lilly announced 10,000,000 liter vials, ten milliliter vials of two types of insulin would be temporarily out of stock in some parts of the country through the beginning of april. many diabetics are finding that the insulin that is available is either not what they were prescribed, or it's not covered by their insurance. >> insulin is insulin, but you have to have the right name brand in order to get it covered , and insurance isn't going to do it if they don't have it, they...
0
0.0
Apr 18, 2024
04/24
by
KNTV
tv
eye 0
favorite 0
quote 0
. >>> eli lilly says zepbound could help treat sleep apnea. a new study shows mentally-stimulating jobs may reduce the risk of dementia. people who arehad the least mentally challenging jobs had a higher risk of dementia. a higher risk of dementia. to attract and trap flying insects with no odor and no mess. they work continuously, so you don't have to. zevo. people-friendly. bug-deadly. ahh. it's a good day to cough. oh no. bye, bye cough. later chest congestion. hello 12 hours of relief. 12 hours!! not coughing at the movies!? hashtag still not coughing?! ahh! mucinex dm 12 hour doesn't just quiet coughs, it treats coughs caused by excess mucus at the source and controls them for 12 hours. it's comeback season. stubborn chest congestion? try mucinex 12 hour. head & shoulders bare clinically proven dandruff protection with just 9 essential ingredients no sulfates, no silicones, no dyes. dandruff protection, minimal ingredients. job done. >>> we are just 99 days away until the 2024 paris olympics. our keir sip psmmons shows us h they're transf
. >>> eli lilly says zepbound could help treat sleep apnea. a new study shows mentally-stimulating jobs may reduce the risk of dementia. people who arehad the least mentally challenging jobs had a higher risk of dementia. a higher risk of dementia. to attract and trap flying insects with no odor and no mess. they work continuously, so you don't have to. zevo. people-friendly. bug-deadly. ahh. it's a good day to cough. oh no. bye, bye cough. later chest congestion. hello 12 hours of...
0
0.0
Apr 28, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
week we will get results from amazon and apple and tackle get hershey, i hope and food were going to eli lilly for drugs. >> alright so megan higher narrative jack said might've upset stocks a little bit certainly upsets people who want to buy a house. what's happening in housing market? >> we've seen a mortgage at rates expanded substantially since march. they have risen to nearly seven-point to percent the past week according to freddie. >> and unfortunately the 10 year treasury yield to suggest more unpleasantness is along for the ride. now of course that's putting as you point out pressure on home bike it is interesting is not showing up in the data quite yet. national association of realtors pending sales for march w markep 3.4%. it's the northeast leading the pack of her once good news for all of us new yorkers. followed by the south in the west. hottest markets right now are definitely in the new york area. the new england even places like north carolina. an interesting trend going on. >> its money back in the housing crisis before the housing crisis we say that all about regional
week we will get results from amazon and apple and tackle get hershey, i hope and food were going to eli lilly for drugs. >> alright so megan higher narrative jack said might've upset stocks a little bit certainly upsets people who want to buy a house. what's happening in housing market? >> we've seen a mortgage at rates expanded substantially since march. they have risen to nearly seven-point to percent the past week according to freddie. >> and unfortunately the 10 year...
0
0.0
tv
eye 0
favorite 0
quote 0
a company like fiers, as an example, would have to add another company the size of eli lilly to make up for some of those expirations. not going to happen. if you suffer from excessive bullishness on big farm a marx i think this cover story will cure you of it. jack: fiers was selling at the same price it was on friday back in 1998. real quick, one bright spot is the obesity drugs, but you're probably going to tell me they're not -- >> yeah, they've already run up, right in and we're about ten years away, plus or minus, for lilly and novo nordisk for them facing the same expirations, so we might go true the whole cycle again -- through the whole cycle. jackie: surprisingly strong the hiring is dimming investors' hopes for rate cut. my next guest doesn't expect a single cut in 2024. he explains next. ♪ ♪3, 4♪ ♪ ♪hey♪ ♪ ♪are you ready for me♪ ♪are you ready♪ ♪are you ready♪ morikawa on 18. he is really boxed in here. -not a good spot. off the comcast business van. into the vending area. oh, not the fries! where's the ball? -anybody see it? oh wait, there it is
a company like fiers, as an example, would have to add another company the size of eli lilly to make up for some of those expirations. not going to happen. if you suffer from excessive bullishness on big farm a marx i think this cover story will cure you of it. jack: fiers was selling at the same price it was on friday back in 1998. real quick, one bright spot is the obesity drugs, but you're probably going to tell me they're not -- >> yeah, they've already run up, right in and we're...
0
0.0
Apr 4, 2024
04/24
by
CSPAN
tv
eye 0
favorite 0
quote 0
in a separate hearing, the ceo of eli lilly committed that his company would not raise prices on existing insulin products after announcing substantial price cuts for these products. these efforts will improve life for millions of americans, present -- prevent unnecessary deaths, and save substantial sums of money for working-class families. but let us be clear. despite all we have accomplished up to now, it is not enough. much more needs to be done. in his state of the union address, president biden called on congress to pass legislation to cap out-of-pocket prescription drug costs for all americans at no more than $2000 a year and to substantially increase the number of drugs that can be negotiated with the pharmaceutical industry. i strongly agree with him. and think of what that will mean to the people in our country, many of whom have chronic illnesses. no more than $2000 out-of-pocket. that is a significant step forward. as chairman of the health committee, i intend to push that legislation as aggressively as i can. in my view, we can no longer tolerate companies charging the americ
in a separate hearing, the ceo of eli lilly committed that his company would not raise prices on existing insulin products after announcing substantial price cuts for these products. these efforts will improve life for millions of americans, present -- prevent unnecessary deaths, and save substantial sums of money for working-class families. but let us be clear. despite all we have accomplished up to now, it is not enough. much more needs to be done. in his state of the union address, president...
0
0.0
Apr 24, 2024
04/24
by
KNTV
tv
eye 0
favorite 0
quote 0
folwell says, the real problem is the price charged by manufacturers eli lilly and denmark-based novo nordisk averaging $1,000 per month. >> we're under siege. something is wrong when a drug can sell for over a thousand dollars in this state and in the home country of where this company is headquartered can sell for less than $300. >> you referred to the drug companies as a cartel. >> right. >> what do you mean by that? >> cartel is defined in the webster's dictionary as an association which is formed to restrict competition or raise prices. i mean, that's what's happening in the prescription drug industry and the hospital drug industry. >> reporter: in statements to nbc news, both companies stress the importance of expanded coverage with novo nordisk saying the state rejected multiple workable options and chose to abandon its obligation to employees living with obesity. other plans including the university of texas and the mayo clinic have already eliminated coverage or scaled it back, as well as some states. meanwhile, providers like leeanne owens and her patients are scrambling wit
folwell says, the real problem is the price charged by manufacturers eli lilly and denmark-based novo nordisk averaging $1,000 per month. >> we're under siege. something is wrong when a drug can sell for over a thousand dollars in this state and in the home country of where this company is headquartered can sell for less than $300. >> you referred to the drug companies as a cartel. >> right. >> what do you mean by that? >> cartel is defined in the webster's...
0
0.0
Apr 18, 2024
04/24
by
KNTV
tv
eye 0
favorite 0
quote 0
the big problem eli lilly is facing right now is a shortage. both zepbound and mounjaro, which is used for diabetes increasingly hard to find at the moment. thousands across the country, tens of thousands, really, not able to get their precipitation dosage filled, and that could last maybe for months. >> reporter: all across the country, america's relationship with weight loss is under going a dramatic transformation. as drugs like ozempic, wegovy, mounjaro and zepbound are changing the game. their popularity is exploding with sales soaring, over $11 billion in 2023, compared to about $4 billion the year before. now demand is exceeding the supply. here in north carolina, a multi-billion-dollar all hands on deck push to churn out mounjaro for diabetes and zepbound for weight loss. a massive investment to bring injectables from this brand-new eli lilly site to your pharmacy. so people -- consumers out there who really are eager for these drugs will see product from here at their pharmacies in the spring? in january? >> some time next year. for su
the big problem eli lilly is facing right now is a shortage. both zepbound and mounjaro, which is used for diabetes increasingly hard to find at the moment. thousands across the country, tens of thousands, really, not able to get their precipitation dosage filled, and that could last maybe for months. >> reporter: all across the country, america's relationship with weight loss is under going a dramatic transformation. as drugs like ozempic, wegovy, mounjaro and zepbound are changing the...
0
0.0
Apr 9, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
no news, just the usual i'm back to the winners, how about eli lilly down 20 bucks? broke ground for the new $2.5 billion plant, another loser term winter for a day. 6%. eyed looked it up and i see one of the most horrendous shortfalls, the first quarter earnings but would be 21 to 41 points. that is a long fall. the red 119 last year. i'm not interested, i'd rather go fishing for flounders. in response to this earnings. about two winners, more than 3% respectively. so many important devices in the data center, still 30%. it was incredibly positive more than 6000 people and it was pretty much the start of the entire survey. the basis point increase. the number two fashion brand among upper female teams. the favored industrial, so many industries. it dominates the non-tech part of the data center. up almost 4%. the analyst came out and said by the stock. they take it hot this year. what a terrific time to pay for the stocks. but you've got no taxes to pay. we can't say that the losers know, i think that is wrong. the bottom line there back today with everything going
no news, just the usual i'm back to the winners, how about eli lilly down 20 bucks? broke ground for the new $2.5 billion plant, another loser term winter for a day. 6%. eyed looked it up and i see one of the most horrendous shortfalls, the first quarter earnings but would be 21 to 41 points. that is a long fall. the red 119 last year. i'm not interested, i'd rather go fishing for flounders. in response to this earnings. about two winners, more than 3% respectively. so many important devices in...
0
0.0
Apr 17, 2024
04/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
new study suggest eli lilly's weight loss drug also helps improve breathing for patients with sleep apnea. if it were to be approved for the condition it would open the door for more patients to access the drug through insurance. next up we have urban outfitters getting a downgrade to and underperform. the analyst excites a challenging year ahead thanks to steep discounts and weakening traffic trends. we have alcoa making the social rounds after news president biden would propose higher tariffs on chinese steel and aluminum during a visit to pittsburgh pennsylvania later this afternoon. you can follow the latest company buzz on your bloomberg terminal. let's take a quick look at the market because it is moving. the s&p 500 we were talking about those gains earlier still in the green. you can see they've come down quite a bit. the s&p 500 up 2/10 of a percent. can't say the same for big tech. the nasdaq down about 2/10 of a percent. constructing zero energy buildings. we will talk to marshall cox about his company's mission of decarbonizing housing. that conversation coming up next, this i
new study suggest eli lilly's weight loss drug also helps improve breathing for patients with sleep apnea. if it were to be approved for the condition it would open the door for more patients to access the drug through insurance. next up we have urban outfitters getting a downgrade to and underperform. the analyst excites a challenging year ahead thanks to steep discounts and weakening traffic trends. we have alcoa making the social rounds after news president biden would propose higher tariffs...
0
0.0
Apr 17, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
stuart: is that -- lauren: the sleep apnea machine at eli lilly says its weight loss drug reduces the severity of the sleep disorder by two thirds. lily is up 1.6%. it is amazing. stuart: thank you very much. president biden marked trump on the campaign trail in pennsylvania yesterday. what did biden say a? lauren: he made fun of donald trump. shares of the president's former media company had fallen sharply. listen to this. >> president biden: i have to say, if trump's stock in truth social, his company, drops any lower, he might do better under my tax plan than his. [applause] lauren: ashley: biden was touting his tax plan vowing nobody under $400,000 will pay extra in taxes. the trump campaign responded to biden's job saying seeing as president biden regularly posts to his campaign account on truth social, we have faith he sees the value of free-speech, social media startup that has no depth, $200 million in the bank. stuart: thanks. seven jurors have been seated in donald trump's hush money trial, 11 more still needed before opening statements can begin. the former acting attorney
stuart: is that -- lauren: the sleep apnea machine at eli lilly says its weight loss drug reduces the severity of the sleep disorder by two thirds. lily is up 1.6%. it is amazing. stuart: thank you very much. president biden marked trump on the campaign trail in pennsylvania yesterday. what did biden say a? lauren: he made fun of donald trump. shares of the president's former media company had fallen sharply. listen to this. >> president biden: i have to say, if trump's stock in truth...
0
0.0
Apr 16, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
lilly, pfizer, viking, all these companies trying to get the oral version, different versions of it. this is an enormous breakthrough and if it prevents the need for surgery, i am offer that exact reason. stuart: i think yet again we are in agreement. i think that's pretty good. see you again soon. a new study, another new study highlight how legalizing marijuana could affect teenage part use. what did the study say? ashley: probably not what you would think. these kids are not going in smoke. and a report found legalizing marijuana for adults for the opening of retail pot stores did not lead to an increase in teens using cannabis. students from 9th to 12th grade in 47 states, the results show legalization and control over cannabis markets did not see more adolescents using weed. but researchers say not all the findings are positive. one outcome should retail pot stores, teenagers who used marijuana did so more frequently after the markets opened with a 26% higher frequency. we are taking studies all the time. stuart: we have at least three new studies every single day. more than hal
lilly, pfizer, viking, all these companies trying to get the oral version, different versions of it. this is an enormous breakthrough and if it prevents the need for surgery, i am offer that exact reason. stuart: i think yet again we are in agreement. i think that's pretty good. see you again soon. a new study, another new study highlight how legalizing marijuana could affect teenage part use. what did the study say? ashley: probably not what you would think. these kids are not going in smoke....
0
0.0
Apr 16, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
contrast that to eli lilly which is steeper . >> david, we will toss things to bertha coombs with the earnings alert on united health. >>> frank, united health revenues beat expectations at $99.8 billion against $99.3 billion estimate. that was led by the optum service division despite the health care unit cyber attack. it is complicated on the bottom line. it is unclear if adjusted earnings of $6.91 a share is comparable to the consensus. that adjusted number is 25 cents per share impact for part of the business disruption and costs from the hack, but excludes costs for advanced payment and interest-free loans due to the system outage which the company says tops $9 billion. united is reaffirming the full-year outlook despite the 30 cents share impact from change disruption costs. those are the headlines. >> united health up over 1% right now. futures right now are in the red. anyothk u to bertha coombs. that will do it for us. "squawk box" is coming up next. thank you for watching. my name is oluseyi and some of my favorite moments throughout my life are watching sports with my dad.
contrast that to eli lilly which is steeper . >> david, we will toss things to bertha coombs with the earnings alert on united health. >>> frank, united health revenues beat expectations at $99.8 billion against $99.3 billion estimate. that was led by the optum service division despite the health care unit cyber attack. it is complicated on the bottom line. it is unclear if adjusted earnings of $6.91 a share is comparable to the consensus. that adjusted number is 25 cents per...
0
0.0
Apr 1, 2024
04/24
by
CNBC
tv
eye 0
favorite 0
quote 0
>> other than some bio tech and eli lilly, the group acts terribly so i am not sure you want to downgrade it here because it lags so much, and especially because earnings grew better than tech, by the way, and you can find your spots within health care. i am underweight and i like ge a lot, and it's a spin out and i think they are doing a better job in execution, margins and market share. i own j&j but it can't get out of its own way. >> are you offsides in health care, jimmy? you are overweight in the space. >> yeah, steph, you caught me by surprise on that. i am overweight. i think this is the snap back trade after 2023, but i think where you and i are having a difference is something key to what you said, you have to pick your spots. bristol myer has been a disaster for a long time and you and i have spoken about that. if you look at cvs, it's showing some signs of life here. i think this is where you are supposed to rotate into but not get out of. >> it's interesting to me that you are as bullish as most of the bulls. >> yep. >> and yet you are overweight what would be considered a de
>> other than some bio tech and eli lilly, the group acts terribly so i am not sure you want to downgrade it here because it lags so much, and especially because earnings grew better than tech, by the way, and you can find your spots within health care. i am underweight and i like ge a lot, and it's a spin out and i think they are doing a better job in execution, margins and market share. i own j&j but it can't get out of its own way. >> are you offsides in health care, jimmy?...
0
0.0
Apr 18, 2024
04/24
by
FBC
tv
eye 0
favorite 0
quote 0
lilly and it makes sense to broad now and really see the other beneficiaries and the other companies that will get hurt from the big major investments that are playing o out. maria: do you think will see a broadening out. for example we've been waiting for small-cap to get a bid for a while now and a lot of people saying small-cap stocks are where you want to be that the broadening out that is expected to have a taken hold yet. >> they have been broadening out we've seen financials do really well, materials, industrials small-cap stocks have had a tough three years and they haven't done much. the reason is interest-rate sensitive we recently upgraded from underweight to neutral with small caps but most small caps unprofitable companies i would've put more than five or 10% of your portfolio in small caps anyways. i think it's going to take some time. regarding the a.i. question that you had. i think this is a huge technological revolution and it's going affect all stocks and make so many companies much more profitable and it's not just about nvidia although that's the posttrial. maria
lilly and it makes sense to broad now and really see the other beneficiaries and the other companies that will get hurt from the big major investments that are playing o out. maria: do you think will see a broadening out. for example we've been waiting for small-cap to get a bid for a while now and a lot of people saying small-cap stocks are where you want to be that the broadening out that is expected to have a taken hold yet. >> they have been broadening out we've seen financials do...